
Susanna Moore
Examiner (ID: 4754)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 1838 |
| Issued Applications | 1086 |
| Pending Applications | 196 |
| Abandoned Applications | 608 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18598555
[patent_doc_number] => 20230273354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA
[patent_app_type] => utility
[patent_app_number] => 18/101009
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101009
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101009 | GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA | Jan 23, 2023 | Abandoned |
Array
(
[id] => 18725734
[patent_doc_number] => 20230339933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHODS FOR THE TREATMENT OF GASTRO-INTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/157783
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/157783 | Methods for the treatment of gastro-intestinal disorders | Jan 19, 2023 | Issued |
Array
(
[id] => 18649372
[patent_doc_number] => 20230295171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => FUSED HETEROAROMATIC PYRROLIDINONES
[patent_app_type] => utility
[patent_app_number] => 18/096392
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096392 | FUSED HETEROAROMATIC PYRROLIDINONES | Jan 11, 2023 | Abandoned |
Array
(
[id] => 18375941
[patent_doc_number] => 20230151022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/089971
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/089971 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | Dec 27, 2022 | Pending |
Array
(
[id] => 18375941
[patent_doc_number] => 20230151022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/089971
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/089971 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | Dec 27, 2022 | Pending |
Array
(
[id] => 18346562
[patent_doc_number] => 20230134672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => KETOROLACO DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/145901
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145901
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145901 | KETOROLACO DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF | Dec 22, 2022 | Pending |
Array
(
[id] => 19701468
[patent_doc_number] => 12195477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Derivative of berberine, and the preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/086397
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 7556
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086397 | Derivative of berberine, and the preparation method and application thereof | Dec 20, 2022 | Issued |
Array
(
[id] => 18955101
[patent_doc_number] => 20240043428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 18/069646
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069646 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | Dec 20, 2022 | Abandoned |
Array
(
[id] => 18524292
[patent_doc_number] => 20230234949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => MORPHOLINYLPYRIDONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/084208
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084208
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084208 | MORPHOLINYLPYRIDONE COMPOUNDS | Dec 18, 2022 | Abandoned |
Array
(
[id] => 18449487
[patent_doc_number] => 20230190763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists
[patent_app_type] => utility
[patent_app_number] => 18/083602
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 952
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083602
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083602 | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists | Dec 18, 2022 | Issued |
Array
(
[id] => 18752392
[patent_doc_number] => 20230355629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => DEUTERATED DERIVATIVES OF RUXOLITINIB
[patent_app_type] => utility
[patent_app_number] => 18/078571
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | Dec 8, 2022 | Pending |
Array
(
[id] => 18307879
[patent_doc_number] => 20230111779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS OF MANUFACTURE OF DIANHYDRIDES
[patent_app_type] => utility
[patent_app_number] => 18/062189
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062189
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062189 | METHODS OF MANUFACTURE OF DIANHYDRIDES | Dec 5, 2022 | Pending |
Array
(
[id] => 18307879
[patent_doc_number] => 20230111779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS OF MANUFACTURE OF DIANHYDRIDES
[patent_app_type] => utility
[patent_app_number] => 18/062189
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062189
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062189 | METHODS OF MANUFACTURE OF DIANHYDRIDES | Dec 5, 2022 | Pending |
Array
(
[id] => 18295270
[patent_doc_number] => 20230104956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/074889
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074889
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074889 | Glucagon receptor antagonist and use thereof | Dec 4, 2022 | Issued |
Array
(
[id] => 18391328
[patent_doc_number] => 20230159546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/989103
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 454
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989103 | NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | Nov 16, 2022 | Pending |
Array
(
[id] => 18391328
[patent_doc_number] => 20230159546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/989103
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 454
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989103 | NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | Nov 16, 2022 | Pending |
Array
(
[id] => 18690888
[patent_doc_number] => 20230321050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Heterocyclic Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/983735
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983735 | Heterocyclic Compounds and Uses Thereof | Nov 8, 2022 | Abandoned |
Array
(
[id] => 18451482
[patent_doc_number] => 20230192760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION
[patent_app_type] => utility
[patent_app_number] => 18/052486
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052486
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052486 | SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION | Nov 2, 2022 | Pending |
Array
(
[id] => 18468779
[patent_doc_number] => 20230203061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
[patent_app_type] => utility
[patent_app_number] => 18/050650
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050650 | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use | Oct 27, 2022 | Issued |
Array
(
[id] => 19667498
[patent_doc_number] => 12180226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Spirotricycle RIPK1 inhibitors and methods of uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/049344
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36388
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049344
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049344 | Spirotricycle RIPK1 inhibitors and methods of uses thereof | Oct 24, 2022 | Issued |